SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Globalisation

Globalisation

Globalisation

When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

German CMO looks to grow US biz through rise in SMEs and virtual pharma

24-Nov-2014 - Rottendorf is looking to break from being “the best kept secret in the CMO world” by targeting the thousands of virtual and SME pharma firms in the US, according to its CEO....

Exclusive interview

INC stock launches up almost 10% as CEO says business as usual

10-Nov-2014 - The IPO boom for CROs is kicking off with INC Research’s stock offering, which as of Friday afternoon saw a nearly 10% rise, meaning the company raised more than $150m.

China sets new requirements for hospitals running clinical trials

10-Nov-2014 - The Chinese authorities are supplementing their current regulations around clinical trials with new mandates for the hospitals that conduct the studies. 

news from cphi

CDMO strategic deals 'the new standard,' say Catalent and DPx, but big and small pharma demands differ

16-Oct-2014 - Strategic relationships with contract manufacturers are becoming the standard, but big and small pharma demands differ considerably according to the two largest CDMOs, DPx and Catalent.

Novotech moves into China with new Shanghai office after requests from US and EU customers

01-Oct-2014 - Australia’s largest clinical CRO Novotech has expanded its services into China with a new office in Shanghai.

Ukraine still attracting Quintiles, PPD, Icon, Parexel and INC says study

22-Sep-2014 - Political instability in Ukraine has not diminished international drug industry desire to conduct clinical trials there according to a new report.

Opinion

Public or private: Where Catalent goes, will other CMOs follow?

18-Sep-2014 - Following the recent IPO from Catalent, has private equity called time on the CDMO industry? Outsourcing-pharma’s Dan Stanton thinks it has for now.

US gov rallies industry to join mission to Indonesia and the Phillipines

18-Sep-2014 - Pharma service companies looking to access the growing Philippine and Indonesian markets have been invited to join a Public-Private trade mission by the US Department of Commerce.

Dispatches from ChemOutsourcing

CMO consolidation: Do biopharma partners see any benefits?

17-Sep-2014 - As contract manufacturers continue to consolidate , some in the industry are questioning whether the resulting companies have the ability to offer the same services as the former individual companies. 

DHL and Octapharma open cold-chain logistics centre in Germany

16-Sep-2014 - In a venture with plasma products manufacturer Octapharma, DHL has opened a €3.4m ($4.4m) cold-chain logistics centre in Germany for the pharma and life sciences industries.

Biologics trials: the ‘stretched’ global supply chain

08-Sep-2014 - The high cost and complexity of producing biopharmaceuticals for clinical trials limits supplies and makes effective logistics even more important than for small molecule studies says Almac.

Synexus acquires fourth trial site in South Africa

01-Sep-2014 - CRO Synexus has expanded its presence in “the gateway to Africa” by acquiring the Helderberg Clinical Trials Centre (HCTC) in Capetown.

SGS expands Shanghai lab in response to growing pharma demand

31-Jul-2014 - Growing pharma demand in China has led SGS Life Sciences to expand its validation testing and lab service offerings at its Shanghai site.

Global trials growth driving CRO consolidation, says M&A report

29-Jul-2014 - Increased emphasis on global clinical trials is promoting consolidation of contract research organisations (CROs), according to an industry report by M&A services firm 11T Partners.

AmerisourceBergen set to pass $100bn sales mark for FY 2014

28-Jul-2014 - AmerisourceBergen has reported “outstanding operational and financial performance” for the third quarter 2014, and is set to pass the $100bn revenue mark for the fiscal year. 

Accovion continues expansions across Europe

23-Jul-2014 - Germany-based full-service CRO (contract research organization) Accovion has expanded European presence with new offices in Italy, France and Eastern Europe. 

Big Pharma's 'intellectual arrogance' stunts CMO partnerships, says GPCM Chair

22-Jul-2014 - Efficient relationships with contract manufacturers are being held back by Big Pharma’s ‘intellectual arrogance’ and ill-defined operational teams, according to an ex-Director at GlaxoSmithKline.

West is East - Indian plant opens to serve Asian-Pacific customers

17-Jul-2014 - West’s new pharmaceutical packaging facility in India will reduce supply lead times for its Asia-Pacific customers, the company says.

CROs see high jobs growth as bio industry remains relatively flat, report finds

15-Jul-2014 - While the overall bioscience industry has seen 7.4% jobs growth between 2001 and 2012, the sector encompassing CROs and other research, testing and medical labs has grown by more than...

Russia set for first foreign CMOs as pharma preps for 2020 policy

09-Jul-2014 - Several international CMOs will establish themselves in Russia over the next few years as pharma looks to satisfy the country's manufacturing policies, the CEO of R-Pharm predicts.

CDSCO issues raft of new trial regulations

07-Jul-2014 - Sponsors and CROs must ensure that clinical studies are properly designed and that investigators work on a maximum of three trials simultaneously under new guidelines issued by Indian regulators.

Clinical Cymru: Simbec Research buys Orion Clinical Services for £12.5m

24-Jun-2014 - Simbec Research has bought Orion Clinical Services in the latest deal backed by the Welsh Government’s £100m life sciences investment fund.

Dispatches from the GPCM Conference, London, UK

For big pharma, ten is the magic number of CMOs says ex-GSK Director

18-Jun-2014 - Big pharma is moving towards strategic partnerships with CMOs, according to speakers at the Global Pharmaceutical Contract Manufacturing (GPCM) Conference, with the ideal number of partners being ten.

Brazil's bureaucracy a barrier to foreign CROs, says expanding Techtrials

10-Jun-2014 - Bureaucracy is the biggest problem in accessing the Brazilian clinical research market, according to local CRO Techtrials, who says its expansion into the US was a far easier procedure.

Adopt highest GMP/GDP standards for Asian clinical trials, says Almac

02-Jun-2014 - Sponsors trialling drugs in Asia should insist on the highest manufacturing standards and consider local production to successfully navigate the varied and complex regulations that govern research in the region...